Symbicort vs Seretide
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| NZ Symbicort | NZ Seretide | |
|---|---|---|
| Generic name | budesonide/formoterol | fluticasone/salmeterol |
| Drug class | Inhaled Corticosteroid + LABA | Inhaled Corticosteroid + LABA |
| Treats | Asthma, COPD | Asthma, COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | GSK |
| Year approved | 2002 | 1999 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $3M | $2M |
| Common side effects | Thrush, Headache, Tremor, Throat irritation | Thrush, Hoarseness, Respiratory infections, Headache |
Symbicort
Frequently asked questions
Is Symbicort or Seretide better?
Neither is universally "better." Symbicort (budesonide/formoterol) and Seretide (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Symbicort and Seretide?
Symbicort is a Inhaled Corticosteroid + LABA made by AstraZeneca, while Seretide is a Inhaled Corticosteroid + LABA made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Symbicort has the larger estimated TV advertising budget of the two.